Andrea Maurichi

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. doi request reprint Pure desmoplastic melanoma: a melanoma with distinctive clinical behavior
    Andrea Maurichi
    Departments of Surgery and Biometry, Fonda zione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Ann Surg 252:1052-7. 2010
  2. ncbi request reprint Pigmented spindle-cell nevus: a melanoma simulator
    Andrea Maurichi
    Melanoma Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Dermatol Online J 10:5. 2004
  3. doi request reprint Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma
    Andrea Anichini
    Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Cancer Res 70:8378-87. 2010
  4. pmc Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response
    Chiara Camisaschi
    Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G Venezian 1, 20133, Milan, Italy
    Cancer Immunol Immunother 62:897-908. 2013
  5. doi request reprint Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage
    Roberta Mortarini
    Department of Experimental Oncology, Human Tumors Immunobiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Clin Cancer Res 15:4085-94. 2009
  6. ncbi request reprint Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival
    Natale Cascinelli
    Nuclear Medicine Unit, Istituto Nazionale Tumori, Milan, Italy
    J Clin Oncol 24:4464-71. 2006
  7. doi request reprint Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes
    Mario Santinami
    Fondazione Istituto Tumori, Milan, Italy
    Melanoma Res 19:112-8. 2009
  8. doi request reprint Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides
    Paola Filipazzi
    Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Clin Cancer Res 18:6485-96. 2012
  9. ncbi request reprint Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry
    Aldo Bono
    Melanoma Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Dermatology 205:362-6. 2002
  10. doi request reprint Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone
    Emilio Bajetta
    Department of Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Via G Venezian 1, Milan, Italy
    Ann Surg Oncol 16:2985-93. 2009

Collaborators

Detail Information

Publications17

  1. doi request reprint Pure desmoplastic melanoma: a melanoma with distinctive clinical behavior
    Andrea Maurichi
    Departments of Surgery and Biometry, Fonda zione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Ann Surg 252:1052-7. 2010
    ..The purpose of the study was to evaluate the excision margin necessary for desmoplastic melanoma (DM)...
  2. ncbi request reprint Pigmented spindle-cell nevus: a melanoma simulator
    Andrea Maurichi
    Melanoma Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Dermatol Online J 10:5. 2004
  3. doi request reprint Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma
    Andrea Anichini
    Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Cancer Res 70:8378-87. 2010
    ..These results suggest development of early phases of antitumor immunity even in advanced melanoma. Moreover, the CD8(+) FOXP3(+) "early effector" subset may be an invaluable tool for monitoring immunity at tumor site...
  4. pmc Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response
    Chiara Camisaschi
    Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G Venezian 1, 20133, Milan, Italy
    Cancer Immunol Immunother 62:897-908. 2013
    ..Despite the Treg expansion that was observed in this study, low-dose IL-2 is not detrimental to the functional activities of vaccine-primed CD8(+) T cell effectors when used in the inflammatory environment of vaccination...
  5. doi request reprint Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage
    Roberta Mortarini
    Department of Experimental Oncology, Human Tumors Immunobiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Clin Cancer Res 15:4085-94. 2009
    ..To assess the extent of signal transducer and activator of transcription (STAT) activation in response to interleukin 2 (IL-2) in melanoma patients' T cells, along with clinical stage of tumor progression...
  6. ncbi request reprint Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival
    Natale Cascinelli
    Nuclear Medicine Unit, Istituto Nazionale Tumori, Milan, Italy
    J Clin Oncol 24:4464-71. 2006
    ....
  7. doi request reprint Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes
    Mario Santinami
    Fondazione Istituto Tumori, Milan, Italy
    Melanoma Res 19:112-8. 2009
    ..This could be considered a standard treatment until new data, provided by ongoing studies, indicate new parameters for selecting patients for completion lymph node dissection...
  8. doi request reprint Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides
    Paola Filipazzi
    Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Clin Cancer Res 18:6485-96. 2012
    ....
  9. ncbi request reprint Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry
    Aldo Bono
    Melanoma Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Dermatology 205:362-6. 2002
    ..Successful treatment of melanoma depends directly on early diagnosis. Such a diagnosis is based on clinical examination and dermatoscopy. Recently, automated instruments for melanoma detection are under development...
  10. doi request reprint Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone
    Emilio Bajetta
    Department of Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Via G Venezian 1, Milan, Italy
    Ann Surg Oncol 16:2985-93. 2009
    ..To determine the long-term outcomes of early-stage Merkel cell carcinoma (MCC) patients managed with surgery alone...
  11. pmc The use of polytetrafluoroethylene to facilitate the vascular access in recurrent melanoma to limbs
    Roberta Ruggeri
    Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Int J Surg Case Rep 4:40-3. 2013
    ..Our aim was to evaluate whether the placement of a polytetrafluoroethylene (PTFE) membrane around vessels might facilitate a surgical re-approach...
  12. ncbi request reprint A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients
    Lorenzo Pilla
    Unit of Immunotherapy of Human Tumors, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Cancer Immunol Immunother 55:958-68. 2006
    ..Clinical activity was limited to SD. However, both immunological and clinical responses were not improved as compared with those recorded in a previous study investigating HSPPC-96 monotherapy...
  13. ncbi request reprint Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma
    Roberta Mortarini
    Human Tumors Immunobiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, 20133, Italy
    Cancer Res 63:2535-45. 2003
    ....
  14. ncbi request reprint Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma
    Paolo Carli
    Department of Dermatology, University of Florence, Via degli Alfani 31, 501221 Florence, Italy
    Arch Dermatol 139:607-12. 2003
    ..To investigate patterns of detection and variables associated with early diagnosis of melanoma in a population at intermediate melanoma risk...
  15. ncbi request reprint Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study
    Paolo Carli
    Department of Dermatology, University of Florence, Florence, Italy
    Dermatol Surg 30:1371-5; discussion 1375-6. 2004
    ..Nodular histotype represents the condition that is mostly associated with diagnosis of thick melanoma...
  16. ncbi request reprint Distribution of melanoma on breast surface suggests its etiology
    Aldo Bono
    Int J Cancer 105:434. 2003
  17. ncbi request reprint SCCA2-like serpins mediate genetic predisposition to skin tumors
    Manuela Gariboldi
    Department of Experimental Oncology, Istituto Nazionale Tumori 20133, Milan, Italy
    Cancer Res 63:1871-5. 2003
    ..These findings provide evidence that SCCA2-like serpins mediate genetic predisposition to skin cancer in a mouse model and in humans...